annb0t
Top 20
Catalent Inc (NYSE: CTLT) agreed to acquire Metrics Contract Services, a full-service specialty Contract Development and Manufacturing Organization, for $475 million from Mayne Pharma Group Limited. Upon completion, the acquisition will strengthen Catalent's integrated oral solid formulation development, manufacturing, and packaging capabilities. The deal will also expand Catalent's capacity to handle highly potent compounds. Metrics Contract operates a 333,000-square-foot facility in Greenville...
>>> Read more: Catalent's New Acquisition will Expand High-Potent Capabilities, Oral Manufacturing Capacity: Report
>>> Read more: Catalent's New Acquisition will Expand High-Potent Capabilities, Oral Manufacturing Capacity: Report
